vs
西铁城（CIA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
西铁城的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$72.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 10.2%，领先373.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 13.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.7%）
西铁城钟表株式会社，又称西铁城集团，是总部位于日本东京西东京市的知名跨国电子企业，核心业务为腕表制造，是西铁城集团的核心企业。除西铁城品牌腕表外，集团还拥有美国钟表公司宝路华，业务同时涵盖计算器、打印机、医疗设备与精密CNC加工设备制造。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CIA vs RIGL — 直观对比
营收规模更大
CIA
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出7.6%
13.5%
净利率更高
RIGL
高出373.9%
10.2%
两年增速更快
RIGL
近两年复合增速
11.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.1M | $69.8M |
| 净利润 | $7.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 10.9% | 33.2% |
| 净利率 | 10.2% | 384.0% |
| 营收同比 | 13.5% | 21.2% |
| 净利润同比 | 102.7% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIARIGL
| Q4 25 | $72.1M | $69.8M | ||
| Q3 25 | $62.8M | $69.5M | ||
| Q2 25 | $65.1M | $101.7M | ||
| Q1 25 | $55.7M | $53.3M | ||
| Q4 24 | $63.5M | $57.6M | ||
| Q3 24 | $61.7M | $55.3M | ||
| Q2 24 | $62.1M | $36.8M | ||
| Q1 24 | $57.7M | $29.5M |
净利润CIARIGL
| Q4 25 | $7.3M | $268.1M | ||
| Q3 25 | $2.4M | $27.9M | ||
| Q2 25 | $6.5M | $59.6M | ||
| Q1 25 | $-1.6M | $11.4M | ||
| Q4 24 | $3.6M | $14.3M | ||
| Q3 24 | $2.8M | $12.4M | ||
| Q2 24 | $4.0M | $-1.0M | ||
| Q1 24 | $4.5M | $-8.2M |
毛利率CIARIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CIARIGL
| Q4 25 | 10.9% | 33.2% | ||
| Q3 25 | 7.1% | 40.9% | ||
| Q2 25 | 10.6% | 60.1% | ||
| Q1 25 | -3.2% | 23.9% | ||
| Q4 24 | 5.9% | 28.9% | ||
| Q3 24 | 4.9% | 25.4% | ||
| Q2 24 | 5.3% | 1.2% | ||
| Q1 24 | 8.5% | -23.6% |
净利率CIARIGL
| Q4 25 | 10.2% | 384.0% | ||
| Q3 25 | 3.8% | 40.2% | ||
| Q2 25 | 9.9% | 58.6% | ||
| Q1 25 | -2.9% | 21.5% | ||
| Q4 24 | 5.7% | 24.9% | ||
| Q3 24 | 4.5% | 22.5% | ||
| Q2 24 | 6.4% | -2.8% | ||
| Q1 24 | 7.9% | -27.9% |
每股收益（稀释后）CIARIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $235.0M | $391.5M |
| 总资产 | $1.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CIARIGL
| Q4 25 | $23.0M | $155.0M | ||
| Q3 25 | $23.1M | $137.1M | ||
| Q2 25 | $22.7M | $108.4M | ||
| Q1 25 | $18.4M | $77.1M | ||
| Q4 24 | $29.3M | $77.3M | ||
| Q3 24 | $32.4M | $61.1M | ||
| Q2 24 | $26.3M | $49.1M | ||
| Q1 24 | $23.2M | $49.5M |
总债务CIARIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CIARIGL
| Q4 25 | $235.0M | $391.5M | ||
| Q3 25 | $225.6M | $117.6M | ||
| Q2 25 | $229.0M | $81.9M | ||
| Q1 25 | $218.1M | $18.6M | ||
| Q4 24 | $210.4M | $3.3M | ||
| Q3 24 | $207.6M | $-14.6M | ||
| Q2 24 | $191.5M | $-29.9M | ||
| Q1 24 | $195.2M | $-31.7M |
总资产CIARIGL
| Q4 25 | $1.8B | $513.6M | ||
| Q3 25 | $1.7B | $242.5M | ||
| Q2 25 | $1.7B | $206.7M | ||
| Q1 25 | $1.7B | $176.0M | ||
| Q4 24 | $1.7B | $164.0M | ||
| Q3 24 | $1.7B | $139.4M | ||
| Q2 24 | $1.7B | $128.4M | ||
| Q1 24 | $1.7B | $126.5M |
负债/权益比CIARIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $17.5M | — |
| 自由现金流率自由现金流/营收 | 24.3% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 2.45× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $26.1M | — |
8季度趋势，按日历期对齐
经营现金流CIARIGL
| Q4 25 | $18.0M | $22.0M | ||
| Q3 25 | $4.7M | $24.0M | ||
| Q2 25 | $3.5M | $30.5M | ||
| Q1 25 | $748.0K | $-893.0K | ||
| Q4 24 | $31.9M | $14.5M | ||
| Q3 24 | $9.7M | $21.7M | ||
| Q2 24 | $4.6M | $302.0K | ||
| Q1 24 | $6.8M | $-5.0M |
自由现金流CIARIGL
| Q4 25 | $17.5M | — | ||
| Q3 25 | $4.6M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $641.0K | — | ||
| Q4 24 | $31.3M | — | ||
| Q3 24 | $9.3M | — | ||
| Q2 24 | $4.5M | — | ||
| Q1 24 | $6.7M | — |
自由现金流率CIARIGL
| Q4 25 | 24.3% | — | ||
| Q3 25 | 7.3% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 49.2% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 11.7% | — |
资本支出强度CIARIGL
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.1% | — |
现金转化率CIARIGL
| Q4 25 | 2.45× | 0.08× | ||
| Q3 25 | 1.93× | 0.86× | ||
| Q2 25 | 0.54× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 8.81× | 1.01× | ||
| Q3 24 | 3.48× | 1.75× | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 1.49× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
